Concepedia

Sumalatha Rani Talapati

SR

Statistics

Publications

2

Citations

165

H-Index

2

Active since

2020

Affiliations

Aurigene Discovery Technologies (India)(Current)

Sumalatha Rani Talapati is an author at Aurigene Discovery Technologies (India) specializing in medicine, pharmacology, and cancer pharmacology.

Publications per year

2020–2021

2

Publications

2

PD-1 derived CA-170 is an oral immune checkpoint inhibitor that exhibits preclinical anti-tumor efficacy

Pottayil G. Sasikumar, Naremaddepalli S. Sudarshan, Srinivas Adurthi et al. · Communications Biology · 2021 · 149 citations · Full text

, , +17

Structure of cyclin-dependent kinase 2 (CDK2) in complex with the specific and potent inhibitor CVT-313

Sumalatha Rani Talapati, Vijayashankar Nataraj, Manoj Pothuganti et al. · Acta Crystallographica Section F Structural Biology Communications · 2020 · 16 citations · Full text

, , +13

1–2 of 2